Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: J Consult Clin Psychol. 2023 Mar 9;91(6):350–366. doi: 10.1037/ccp0000805

Table 1.

Pre-treatment and Demographic Characteristics of Intent-to-Treat Sample Receiving Positive Affect Treatment (PAT) or Negative Affect Treatment (NAT)

Valuea
Characteristics Total (N = 85) PAT (n = 42) NAT (n = 43)
Age, M (SD), years 31.73 (12.3) 31.95 (11.5) 31.51 (13.1)
Female sex 67 (78.8) 31 (73.8) 36 (83.7)
Race/Ethnicity
 White 53 (62.4) 28 (66.7) 25 (58.1)
 Asian 17 (20.0) 8 (19.0) 9 (20.9)
 Alaska Native/Native American/Indigenous 1 (1.2) 1 (2.4) 0 (0.0)
 Pacific Islander/Native Hawaiian 1 (1.2) 0 (0.0) 1 (2.3)
 Black or African American 5 (5.9) 2 (4.8) 3 (7.0)
 Hispanic/Latino (White) 15 (17.6) 6 (14.3) 9 (20.9)
 Hispanic/Latino (non-White) 8 (9.4) 4 (9.5) 4 (9.3)
 Multiracial 4 (4.7) 3 (7.1) 1 (2.3)
 Other 8 (9.4) 1 (2.4) 7 (16.3)
Marital status
 Married 19 (22.4) 9 (21.4) 10 (23.3)
 Single, in a relationship 23 (27.1) 10 (23.8) 13 (30.2)
 Single, not in a relationship 38 (44.7) 19 (45.2) 19 (44.2)
 Separated 2 (2.4) 1 (2.4) 1 (2.3)
 Divorced 3 (3.5) 3 (7.1) 0 (0.0)
Employed full or part time 61 (71.8) 32 (76.2) 29 (67.4)
Education level
 High school diploma/GED 10 (11.8) 3 (7.1) 7 (16.3)
 Some college or a 2-year degree 26 (30.6) 15 (35.7) 11 (25.6)
 4-year college degree 24 (28.2) 11 (26.2) 13 (30.2)
 Graduate degree 25 (29.4) 13 (31.0) 12 (27.9)
Income
 <$10,000 14 (16.5) 7 (16.7) 7 (16.3)
 $10,001-30,000 11 (12.9) 5 (11.9) 6 (14.0)
 $30,001-50,000 16 (18.8) 11 (26.2) 5 (11.6)
 $50,001-70,000 11 (12.9) 6 (14.3) 5 (11.6)
 >$70,000 33 (38.8) 13 (31.0) 20 (46.5)
Current psychotropic medication 24 (28.2) 12 (28.6) 12 (27.9)
Any diagnosis 76 (89.4) 37 (88.1) 39 (90.7)
Depressive diagnoses 58 (68.2) 27 (64.3) 31 (72.1)
 Major depressive disorder 46 (54.1) 19 (45.2) 27 (62.8)
 Persistent depressive disorder 33 (38.8) 17 (40.5) 16 (37.2)
Anxiety diagnoses 50 (58.8) 24 (57.1) 26 (60.5)
 Panic disorder 10 (11.8) 5 (11.9) 5 (11.6)
 Agoraphobia 3 (3.5) 1 (2.4) 2 (4.7)
 Social anxiety disorder 34 (40.0) 17 (40.5) 17 (39.5)
 Generalized anxiety disorder 31 (36.5) 15 (35.7) 16 (37.2)
 Specific phobia 7 (8.2) 3 (7.1) 4 (9.3)
Posttraumatic stress disorder 3 (3.5) 0 (0.0) 3 (7.0)
Obsessive compulsive disorder 3 (3.5) 0 (0.0) 3 (7.0)
Attention deficit hyperactivity 14 (16.5) 9 (21.4) 5 (11.6)
Adjustment disorder 2 (2.4) 1 (2.4) 1 (2.3)

Data are presented as number (percentage) of patients unless otherwise indicated.